nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CYP1A2—Imiquimod—skin cancer	0.158	0.178	CbGbCtD
Promazine—CYP2C19—Vismodegib—skin cancer	0.119	0.134	CbGbCtD
Promazine—CYP2C9—Vismodegib—skin cancer	0.0987	0.111	CbGbCtD
Promazine—CYP1A2—Vemurafenib—skin cancer	0.0866	0.0977	CbGbCtD
Promazine—CYP3A4—Temozolomide—skin cancer	0.0828	0.0934	CbGbCtD
Promazine—CYP3A4—Imiquimod—skin cancer	0.0828	0.0934	CbGbCtD
Promazine—CYP1A2—Dacarbazine—skin cancer	0.0663	0.0749	CbGbCtD
Promazine—CYP3A4—Vismodegib—skin cancer	0.0574	0.0648	CbGbCtD
Promazine—CYP3A4—Vemurafenib—skin cancer	0.0453	0.0512	CbGbCtD
Promazine—CYP1A2—Fluorouracil—skin cancer	0.0389	0.0439	CbGbCtD
Promazine—CYP2C9—Fluorouracil—skin cancer	0.035	0.0396	CbGbCtD
Promazine—CYP3A4—Docetaxel—skin cancer	0.0156	0.0176	CbGbCtD
Promazine—CHRM3—muscle of abdomen—skin cancer	0.0108	0.123	CbGeAlD
Promazine—HRH1—nose—skin cancer	0.00836	0.0949	CbGeAlD
Promazine—CHRM5—skin epidermis—skin cancer	0.00707	0.0803	CbGeAlD
Promazine—DRD1—nerve—skin cancer	0.00513	0.0583	CbGeAlD
Promazine—HTR2A—hindlimb—skin cancer	0.00329	0.0374	CbGeAlD
Promazine—DRD2—nerve—skin cancer	0.00303	0.0344	CbGeAlD
Promazine—HTR2A—appendage—skin cancer	0.00282	0.0321	CbGeAlD
Promazine—CHRM5—epithelium—skin cancer	0.0023	0.0262	CbGeAlD
Promazine—CHRM5—skin of body—skin cancer	0.00219	0.0249	CbGeAlD
Promazine—ADRA1D—epithelium—skin cancer	0.00206	0.0234	CbGeAlD
Promazine—HTR2A—nerve—skin cancer	0.002	0.0227	CbGeAlD
Promazine—CHRM4—head—skin cancer	0.00183	0.0208	CbGeAlD
Promazine—HTR2A—endothelium—skin cancer	0.0017	0.0193	CbGeAlD
Promazine—HTR2A—blood vessel—skin cancer	0.00157	0.0178	CbGeAlD
Promazine—ADRA1D—female reproductive system—skin cancer	0.00153	0.0174	CbGeAlD
Promazine—CYP1A2—nipple—skin cancer	0.00145	0.0165	CbGeAlD
Promazine—CHRM5—head—skin cancer	0.00143	0.0162	CbGeAlD
Promazine—HRH1—nipple—skin cancer	0.00136	0.0154	CbGeAlD
Promazine—ADRA2A—nipple—skin cancer	0.00134	0.0152	CbGeAlD
Promazine—ADRA1B—head—skin cancer	0.00131	0.0148	CbGeAlD
Promazine—ADRA1D—head—skin cancer	0.00128	0.0145	CbGeAlD
Promazine—DRD1—head—skin cancer	0.00122	0.0138	CbGeAlD
Promazine—ADRA1A—epithelium—skin cancer	0.00118	0.0134	CbGeAlD
Promazine—HTR2C—female reproductive system—skin cancer	0.00113	0.0129	CbGeAlD
Promazine—HTR2A—neck—skin cancer	0.00112	0.0128	CbGeAlD
Promazine—CHRM1—female reproductive system—skin cancer	0.00107	0.0121	CbGeAlD
Promazine—CHRM2—head—skin cancer	0.000982	0.0111	CbGeAlD
Promazine—HRH1—connective tissue—skin cancer	0.000964	0.011	CbGeAlD
Promazine—CHRM3—female reproductive system—skin cancer	0.000957	0.0109	CbGeAlD
Promazine—ADRA2A—connective tissue—skin cancer	0.000947	0.0108	CbGeAlD
Promazine—HTR2C—head—skin cancer	0.000946	0.0107	CbGeAlD
Promazine—HRH1—epithelium—skin cancer	0.000916	0.0104	CbGeAlD
Promazine—ADRA1A—lymphoid tissue—skin cancer	0.000911	0.0103	CbGeAlD
Promazine—CHRM1—head—skin cancer	0.000893	0.0101	CbGeAlD
Promazine—HTR2A—connective tissue—skin cancer	0.000805	0.00915	CbGeAlD
Promazine—CHRM3—head—skin cancer	0.0008	0.00908	CbGeAlD
Promazine—HRH1—mammalian vulva—skin cancer	0.000794	0.00902	CbGeAlD
Promazine—ADRA2A—mammalian vulva—skin cancer	0.00078	0.00886	CbGeAlD
Promazine—HTR2A—epithelium—skin cancer	0.000765	0.00869	CbGeAlD
Promazine—ADRA1A—head—skin cancer	0.000734	0.00834	CbGeAlD
Promazine—DRD2—head—skin cancer	0.00072	0.00817	CbGeAlD
Promazine—CYP2C9—female reproductive system—skin cancer	0.00069	0.00783	CbGeAlD
Promazine—HRH1—female reproductive system—skin cancer	0.00068	0.00772	CbGeAlD
Promazine—ADRA2A—female reproductive system—skin cancer	0.000668	0.00759	CbGeAlD
Promazine—HRH1—head—skin cancer	0.000568	0.00645	CbGeAlD
Promazine—HTR2A—female reproductive system—skin cancer	0.000568	0.00645	CbGeAlD
Promazine—ADRA2A—head—skin cancer	0.000558	0.00634	CbGeAlD
Promazine—CYP3A4—female reproductive system—skin cancer	0.000526	0.00597	CbGeAlD
Promazine—HTR2A—head—skin cancer	0.000475	0.00539	CbGeAlD
Promazine—HRH1—lymph node—skin cancer	0.000398	0.00452	CbGeAlD
Promazine—ADRA2A—lymph node—skin cancer	0.000391	0.00444	CbGeAlD
Promazine—HTR2C—Signaling Pathways—SMO—skin cancer	1.57e-05	0.000601	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—ENO2—skin cancer	1.56e-05	0.000599	CbGpPWpGaD
Promazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	1.56e-05	0.000598	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—FOXO4—skin cancer	1.55e-05	0.000596	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—PTGER4—skin cancer	1.52e-05	0.000585	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—PTCH1—skin cancer	1.5e-05	0.000575	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SMO—skin cancer	1.5e-05	0.000575	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CSPG4—skin cancer	1.48e-05	0.000569	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—PTGER4—skin cancer	1.46e-05	0.00056	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SHH—skin cancer	1.46e-05	0.00056	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—RASA1—skin cancer	1.45e-05	0.000556	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SHH—skin cancer	1.43e-05	0.000551	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SHH—skin cancer	1.43e-05	0.000549	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SHH—skin cancer	1.43e-05	0.000548	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—RASA1—skin cancer	1.42e-05	0.000547	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—RASA1—skin cancer	1.42e-05	0.000546	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SHH—skin cancer	1.42e-05	0.000546	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—RASA1—skin cancer	1.42e-05	0.000544	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—RASA1—skin cancer	1.41e-05	0.000542	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SHH—skin cancer	1.41e-05	0.000541	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SHH—skin cancer	1.4e-05	0.000539	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—RASA1—skin cancer	1.4e-05	0.000537	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—RASA1—skin cancer	1.4e-05	0.000536	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SMO—skin cancer	1.38e-05	0.00053	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PTCH1—skin cancer	1.38e-05	0.00053	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PTCH1—skin cancer	1.36e-05	0.000522	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SMO—skin cancer	1.36e-05	0.000522	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PTCH1—skin cancer	1.36e-05	0.000521	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SMO—skin cancer	1.36e-05	0.000521	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SMO—skin cancer	1.35e-05	0.000519	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PTCH1—skin cancer	1.35e-05	0.000519	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SMO—skin cancer	1.35e-05	0.000517	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PTCH1—skin cancer	1.35e-05	0.000517	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—FOXO4—skin cancer	1.35e-05	0.000517	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PTGER4—skin cancer	1.34e-05	0.000516	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PTCH1—skin cancer	1.33e-05	0.000512	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SMO—skin cancer	1.33e-05	0.000512	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PTCH1—skin cancer	1.33e-05	0.000511	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SMO—skin cancer	1.33e-05	0.000511	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PTGER4—skin cancer	1.32e-05	0.000508	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PTGER4—skin cancer	1.32e-05	0.000507	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PTGER4—skin cancer	1.32e-05	0.000505	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PTGER4—skin cancer	1.31e-05	0.000504	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SHH—skin cancer	1.3e-05	0.000501	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PTGER4—skin cancer	1.3e-05	0.000499	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—RASA1—skin cancer	1.3e-05	0.000498	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PTGER4—skin cancer	1.3e-05	0.000497	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—FOXO4—skin cancer	1.29e-05	0.000495	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CSPG4—skin cancer	1.27e-05	0.000486	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SMO—skin cancer	1.24e-05	0.000475	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTCH1—skin cancer	1.24e-05	0.000475	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PLIN2—skin cancer	1.21e-05	0.000466	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTGER4—skin cancer	1.2e-05	0.000462	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—FOXO4—skin cancer	1.19e-05	0.000456	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—FOXO4—skin cancer	1.17e-05	0.000449	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TERT—skin cancer	1.17e-05	0.000448	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—FOXO4—skin cancer	1.17e-05	0.000448	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—FOXO4—skin cancer	1.16e-05	0.000446	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—FOXO4—skin cancer	1.16e-05	0.000445	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TERT—skin cancer	1.15e-05	0.000442	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—FOXO4—skin cancer	1.15e-05	0.000441	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—FOXO4—skin cancer	1.14e-05	0.000439	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ENO2—skin cancer	1.11e-05	0.000424	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TERT—skin cancer	1.1e-05	0.000423	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	1.06e-05	0.000408	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TERT—skin cancer	1.05e-05	0.000403	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—NRAS—skin cancer	1.04e-05	0.0004	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TERT—skin cancer	1.04e-05	0.000398	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ENO2—skin cancer	1.01e-05	0.000387	CbGpPWpGaD
Promazine—CHRM3—Metabolism—ERCC2—skin cancer	9.88e-06	0.000379	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—NRAS—skin cancer	9.84e-06	0.000378	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CSPG4—skin cancer	9.78e-06	0.000375	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—NRAS—skin cancer	9.7e-06	0.000373	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—NRAS—skin cancer	9.29e-06	0.000357	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—BRAF—skin cancer	9.24e-06	0.000355	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—BRAF—skin cancer	9.12e-06	0.00035	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—ERCC2—skin cancer	9.06e-06	0.000348	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TERT—skin cancer	8.99e-06	0.000345	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—KRAS—skin cancer	8.97e-06	0.000345	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—NRAS—skin cancer	8.85e-06	0.00034	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—NRAS—skin cancer	8.74e-06	0.000335	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—BRAF—skin cancer	8.73e-06	0.000335	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.64e-06	0.000332	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ENO2—skin cancer	8.61e-06	0.000331	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TERT—skin cancer	8.61e-06	0.00033	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—KRAS—skin cancer	8.46e-06	0.000325	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—KRAS—skin cancer	8.35e-06	0.000321	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—BRAF—skin cancer	8.32e-06	0.00032	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—BRAF—skin cancer	8.21e-06	0.000315	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—KRAS—skin cancer	8e-06	0.000307	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—TP53—skin cancer	7.98e-06	0.000306	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TERT—skin cancer	7.93e-06	0.000305	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.88e-06	0.000303	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TERT—skin cancer	7.81e-06	0.0003	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TERT—skin cancer	7.79e-06	0.000299	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TERT—skin cancer	7.77e-06	0.000298	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TERT—skin cancer	7.74e-06	0.000297	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TERT—skin cancer	7.67e-06	0.000294	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TERT—skin cancer	7.64e-06	0.000294	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—HRAS—skin cancer	7.63e-06	0.000293	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—KRAS—skin cancer	7.62e-06	0.000293	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—NRAS—skin cancer	7.57e-06	0.000291	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—KRAS—skin cancer	7.52e-06	0.000289	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—NRAS—skin cancer	7.25e-06	0.000278	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—HRAS—skin cancer	7.2e-06	0.000276	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—BRAF—skin cancer	7.12e-06	0.000273	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TERT—skin cancer	7.1e-06	0.000273	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—HRAS—skin cancer	7.1e-06	0.000273	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—IL6—skin cancer	6.89e-06	0.000264	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—BRAF—skin cancer	6.82e-06	0.000262	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—HRAS—skin cancer	6.8e-06	0.000261	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—IL6—skin cancer	6.79e-06	0.000261	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.74e-06	0.000259	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—NRAS—skin cancer	6.68e-06	0.000257	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ENO2—skin cancer	6.65e-06	0.000255	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—NRAS—skin cancer	6.58e-06	0.000253	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—NRAS—skin cancer	6.56e-06	0.000252	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—NRAS—skin cancer	6.54e-06	0.000251	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—NRAS—skin cancer	6.52e-06	0.00025	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—KRAS—skin cancer	6.52e-06	0.00025	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—IL6—skin cancer	6.51e-06	0.00025	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—HRAS—skin cancer	6.48e-06	0.000249	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—NRAS—skin cancer	6.46e-06	0.000248	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	6.44e-06	0.000247	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ERCC2—skin cancer	6.42e-06	0.000246	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—HRAS—skin cancer	6.39e-06	0.000245	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—BRAF—skin cancer	6.28e-06	0.000241	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—KRAS—skin cancer	6.24e-06	0.00024	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—IL6—skin cancer	6.2e-06	0.000238	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—BRAF—skin cancer	6.18e-06	0.000237	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—BRAF—skin cancer	6.17e-06	0.000237	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—BRAF—skin cancer	6.15e-06	0.000236	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—BRAF—skin cancer	6.13e-06	0.000235	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—IL6—skin cancer	6.12e-06	0.000235	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—BRAF—skin cancer	6.07e-06	0.000233	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—BRAF—skin cancer	6.05e-06	0.000232	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	5.98e-06	0.00023	CbGpPWpGaD
Promazine—CHRM3—Metabolism—PTGS2—skin cancer	5.92e-06	0.000227	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ERCC2—skin cancer	5.85e-06	0.000225	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—NRAS—skin cancer	5.81e-06	0.000223	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—KRAS—skin cancer	5.75e-06	0.000221	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—NRAS—skin cancer	5.73e-06	0.00022	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—KRAS—skin cancer	5.66e-06	0.000217	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—KRAS—skin cancer	5.65e-06	0.000217	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—KRAS—skin cancer	5.63e-06	0.000216	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—BRAF—skin cancer	5.62e-06	0.000216	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—KRAS—skin cancer	5.61e-06	0.000216	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—KRAS—skin cancer	5.56e-06	0.000213	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	5.54e-06	0.000213	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—HRAS—skin cancer	5.54e-06	0.000213	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—NRAS—skin cancer	5.49e-06	0.000211	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PTGS2—skin cancer	5.43e-06	0.000209	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—HRAS—skin cancer	5.3e-06	0.000204	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—IL6—skin cancer	5.3e-06	0.000204	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—NRAS—skin cancer	5.23e-06	0.000201	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—NRAS—skin cancer	5.16e-06	0.000198	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	5.15e-06	0.000198	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—IL6—skin cancer	5.08e-06	0.000195	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ERCC2—skin cancer	5e-06	0.000192	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—KRAS—skin cancer	5e-06	0.000192	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—KRAS—skin cancer	4.93e-06	0.000189	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—HRAS—skin cancer	4.89e-06	0.000188	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—HRAS—skin cancer	4.81e-06	0.000185	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—HRAS—skin cancer	4.8e-06	0.000184	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—HRAS—skin cancer	4.79e-06	0.000184	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—HRAS—skin cancer	4.77e-06	0.000183	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—HRAS—skin cancer	4.72e-06	0.000181	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—KRAS—skin cancer	4.72e-06	0.000181	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	4.71e-06	0.000181	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—IL6—skin cancer	4.68e-06	0.00018	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—IL6—skin cancer	4.61e-06	0.000177	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—IL6—skin cancer	4.6e-06	0.000176	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—IL6—skin cancer	4.58e-06	0.000176	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—IL6—skin cancer	4.57e-06	0.000175	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—IL6—skin cancer	4.52e-06	0.000174	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—IL6—skin cancer	4.51e-06	0.000173	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—KRAS—skin cancer	4.5e-06	0.000173	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—NRAS—skin cancer	4.47e-06	0.000172	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TP53—skin cancer	4.44e-06	0.000171	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—KRAS—skin cancer	4.44e-06	0.000171	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TP53—skin cancer	4.38e-06	0.000168	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	4.38e-06	0.000168	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NRAS—skin cancer	4.28e-06	0.000164	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HRAS—skin cancer	4.25e-06	0.000163	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TP53—skin cancer	4.2e-06	0.000161	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HRAS—skin cancer	4.19e-06	0.000161	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—skin cancer	4.19e-06	0.000161	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—skin cancer	4.07e-06	0.000156	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HRAS—skin cancer	4.02e-06	0.000154	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—skin cancer	4.01e-06	0.000154	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TP53—skin cancer	4e-06	0.000154	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NRAS—skin cancer	3.95e-06	0.000152	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TP53—skin cancer	3.95e-06	0.000152	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NRAS—skin cancer	3.89e-06	0.000149	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NRAS—skin cancer	3.88e-06	0.000149	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NRAS—skin cancer	3.86e-06	0.000148	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ERCC2—skin cancer	3.86e-06	0.000148	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NRAS—skin cancer	3.85e-06	0.000148	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—KRAS—skin cancer	3.85e-06	0.000148	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTGS2—skin cancer	3.85e-06	0.000148	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—skin cancer	3.84e-06	0.000148	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HRAS—skin cancer	3.83e-06	0.000147	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NRAS—skin cancer	3.82e-06	0.000146	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NRAS—skin cancer	3.8e-06	0.000146	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HRAS—skin cancer	3.78e-06	0.000145	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—KRAS—skin cancer	3.69e-06	0.000142	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—skin cancer	3.66e-06	0.000141	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—skin cancer	3.61e-06	0.000139	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NRAS—skin cancer	3.54e-06	0.000136	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTGS2—skin cancer	3.51e-06	0.000135	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TP53—skin cancer	3.42e-06	0.000131	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—KRAS—skin cancer	3.4e-06	0.00013	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—KRAS—skin cancer	3.34e-06	0.000128	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—KRAS—skin cancer	3.34e-06	0.000128	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—KRAS—skin cancer	3.33e-06	0.000128	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—KRAS—skin cancer	3.32e-06	0.000127	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—KRAS—skin cancer	3.28e-06	0.000126	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TP53—skin cancer	3.28e-06	0.000126	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—KRAS—skin cancer	3.27e-06	0.000126	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HRAS—skin cancer	3.27e-06	0.000126	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HRAS—skin cancer	3.13e-06	0.00012	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—skin cancer	3.13e-06	0.00012	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—KRAS—skin cancer	3.04e-06	0.000117	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TP53—skin cancer	3.02e-06	0.000116	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTGS2—skin cancer	3e-06	0.000115	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—skin cancer	3e-06	0.000115	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TP53—skin cancer	2.97e-06	0.000114	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TP53—skin cancer	2.97e-06	0.000114	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TP53—skin cancer	2.96e-06	0.000114	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TP53—skin cancer	2.95e-06	0.000113	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TP53—skin cancer	2.92e-06	0.000112	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TP53—skin cancer	2.91e-06	0.000112	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HRAS—skin cancer	2.89e-06	0.000111	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HRAS—skin cancer	2.84e-06	0.000109	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HRAS—skin cancer	2.84e-06	0.000109	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HRAS—skin cancer	2.83e-06	0.000109	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HRAS—skin cancer	2.82e-06	0.000108	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HRAS—skin cancer	2.79e-06	0.000107	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HRAS—skin cancer	2.78e-06	0.000107	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—skin cancer	2.77e-06	0.000106	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—skin cancer	2.72e-06	0.000104	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—skin cancer	2.71e-06	0.000104	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—skin cancer	2.71e-06	0.000104	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TP53—skin cancer	2.7e-06	0.000104	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—skin cancer	2.7e-06	0.000104	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—skin cancer	2.67e-06	0.000103	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—skin cancer	2.66e-06	0.000102	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HRAS—skin cancer	2.59e-06	9.93e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—skin cancer	2.48e-06	9.5e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTGS2—skin cancer	2.31e-06	8.89e-05	CbGpPWpGaD
